Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

被引：0
|
作者：
Heinz Reichmann
Andrew Lees
José-Francisco Rocha
Diogo Magalhães
Patrício Soares-da-Silva
机构：
[1] University of Dresden,Department of Neurology
[2] Reta Lila Weston Institute,University College London
[3] BIAL – Portela & CA S.A,Global Parkinson’s Disease Department
[4] BIAL – Portela & CA S. A,Research and Development Department
[5] da Siderurgia Nacional,Department of Pharmacology and Therapeutics
[6] Faculty of Medicine,MedInUP, Center for Drug Discovery and Innovative Medicines
[7] University Porto,undefined
[8] University Porto,undefined
来源：
Translational Neurodegeneration | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An amendment to this paper has been published and can be accessed via the original article.
引用
收藏
相关论文
共 50 条
  • [41] Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson's Disease
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2023, 38 : S22 - S22
  • [42] Effects of Opicapone on Sleep in Patients with Parkinson's Disease and Motor Fluctuations
    Hauser, R.
    Videnovic, A.
    Soares-da-Silva, P.
    Liang, G.
    Olson, K.
    Jen, E.
    Rocha, J. F.
    Klepitskaya, O.
    MOVEMENT DISORDERS, 2021, 36 : S175 - S176
  • [43] EFFICACY AND SAFETY OF OPICAPONE IN PATIENTS OVER 70 YEARS WITH PARKINSON'S DISEASE AND MOTOR FLUCTUATIONS
    Lees, A.
    Ferreira, J.
    Costa, R.
    Santos, A.
    Rocha, J.
    Soares-Da-Silva, P.
    AGE AND AGEING, 2019, 48
  • [44] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of monoamine-oxidase-b inhibitors and dopamine agonists: The real-world OPTIPARK study
    Reichmann, Heinz
    Warnecke, Tobias
    Lees, Andrew
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 272 - 273
  • [45] Evaluating the efficacy and safety of opicapone in patients over 70 years with Parkinson's disease and motor fluctuations
    Lees, A.
    Ferreira, J.
    Lopes, N.
    Costa, R.
    Santos, A.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 438 - 438
  • [46] Subcutaneous Levodopa Infusion for Parkinson's disease Patients with Motor Fluctuations: Open-Label Efficacy Outcomes from the BeyoND study
    Poewe, W.
    Stocchi, F.
    Adar, L.
    Case, R.
    Yardeni, T.
    Espay, A.
    MOVEMENT DISORDERS, 2021, 36 : S191 - S191
  • [47] ADOPTION Study: Status update of a Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson's Disease
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2022, 37 : S327 - S327
  • [48] ADOPTION Study: Status Update of a Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson's Disease
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Stocchi, F.
    Antonini, A.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 451 - 451
  • [49] Influence of demographic features in Opicapone effectiveness in Parkinson's patients: the real-world OPTIPARK study
    Mohamed, B.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 903 - 903
  • [50] Efficacy, tolerability and adherence of opicapone for Parkinson's disease patients with motor fluctuations
    Bermejo Velasco, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 454 - 454
12345